Our core areas of expertise are Gum, Pharma and Nicotine. Our competencies within these three pillars of expertise are deeply rooted in our proud history, along with our commitment to quality and innovation. This is why Fertin Pharma is the leading B2B partner in medicated chewing gum.


At Fertin Pharma we are experts in the complex challenge of developing medicated chewing gum. Adding active substances to chewing gum is not a simple task and it requires some of the world’s leading experts in the area. Our R&D department employs highly qualified employees, an indispensable part of our organization.

As a delivery system for active substances, chewing gum has unique benefits that set it apart from traditional forms such as tablets. Chewing gum is convenient, healthy and enjoyable, providing the end user with a consumer experience in line with some of the latest confectionery gum trends – and ultimately may help improve patient adherence to medical treatment plans.

We employ two successful gum technologies for our medicated chewing gum products. Our extruded chewing gum technology is utilized for our nicotine chewing gum and our Medichew® technology is used for other products.


Our pharmaceutical expertise is the foundation behind Fertin’s position as a preferred partner for medicated gum

More than 30 years of experience with medicated chewing gum provides Fertin with substantial know-how related to the development and production of medicated chewing gum for pharmaceutical applications. Our goal is to create world class pharmaceutical products, which is why we promote a compliance mentality throughout the organization that is focused on making high-quality medicated chewing gum.


On a global scale 6 million people die each year from tobacco related diseases, so it is no surprise that the WHO characterizes this as an epidemic. At Fertin Pharma, we believe that the understanding of nicotine and its use is instrumental in challenging this epidemic, thereby supporting healthier living.